Skip to main content
. 2014 Aug 29;47(1):26–33. doi: 10.4143/crt.2013.208

Fig. 1.

Fig. 1.

Various treatment outcomes according to axillary node status reflect an uneven tumor response to chemotherapy by each metastatic lymph node. Residual non-sentinel node metastasis after chemotherapy could raise concerns regarding application of sentinel lymph node (SLN) biopsy for patients receiving neoadjuvant chemo- therapy (red arrow).